|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07H 1/00 | (2006.01) |
| C07H 21/00 | (2006.01) | ||
| C12N 9/00 | (2006.01) |
| (11) | Number of the document | 3481838 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17739936.7 |
| Date of filing the European patent application | 2017-07-07 | |
| (97) | Date of publication of the European application | 2019-05-15 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-19 |
| (46) | Date of publication of the claims translation | 2020-12-10 |
| (86) | Number | PCT/EP2017/067049 |
| Date | 2017-07-07 |
| (87) | Number | WO 2018/011067 |
| Date | 2018-01-18 |
| (30) | Number | Date | Country code |
| 201612011 | 2016-07-11 | GB |
| (72) |
CRAMERI, Andreas, GB
HILL, Malcolm Leithhead, GB
LOVELOCK, Sarah Louise, GB
SCHOBER, Markus, GB
TEW, David Graham, GB
THOMAS, Pamela Joan, GB
|
| (73) |
GlaxoSmithKline Intellectual Property Development Limited,
980 Great West Road, Brentford Middlesex TW8 9GS,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Nauji oligonukleotidų gamybos būdai |
| NOVEL PROCESSES FOR THE PRODUCTION OF OLIGONUCLEOTIDES |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 9 | 208.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2025-04-01 |